Published in Genome Res on July 03, 2012
Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med (2013) 19.87
Mutational landscape and significance across 12 major cancer types. Nature (2013) 14.91
Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes. Nature (2012) 8.31
Emerging landscape of oncogenic signatures across human cancers. Nat Genet (2013) 6.48
Genomic landscape of non-small cell lung cancer in smokers and never-smokers. Cell (2012) 6.09
Comprehensive identification of mutational cancer driver genes across 12 tumor types. Sci Rep (2013) 3.92
Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas. Nat Genet (2013) 3.51
Cumulative haploinsufficiency and triplosensitivity drive aneuploidy patterns and shape the cancer genome. Cell (2013) 3.26
Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun (2013) 2.94
Pan-cancer network analysis identifies combinations of rare somatic mutations across pathways and protein complexes. Nat Genet (2014) 2.91
Clonal diversity of recurrently mutated genes in myelodysplastic syndromes. Leukemia (2013) 2.85
Epigenomic alterations define lethal CIMP-positive ependymomas of infancy. Nature (2014) 2.81
Exome sequencing identifies mutation in CNOT3 and ribosomal genes RPL5 and RPL10 in T-cell acute lymphoblastic leukemia. Nat Genet (2012) 2.64
Emerging patterns of somatic mutations in cancer. Nat Rev Genet (2013) 2.50
Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma. Nat Genet (2013) 2.42
Spectrum of diverse genomic alterations define non-clear cell renal carcinoma subtypes. Nat Genet (2014) 2.11
Enabling transparent and collaborative computational analysis of 12 tumor types within The Cancer Genome Atlas. Nat Genet (2013) 1.80
Genomic landscape of carcinogen-induced and genetically induced mouse skin squamous cell carcinoma. Nat Med (2015) 1.80
Simultaneous identification of multiple driver pathways in cancer. PLoS Comput Biol (2013) 1.71
Computational approaches to identify functional genetic variants in cancer genomes. Nat Methods (2013) 1.64
Genomic landscape of Ewing sarcoma defines an aggressive subtype with co-association of STAG2 and TP53 mutations. Cancer Discov (2014) 1.63
Mutational landscape of gingivo-buccal oral squamous cell carcinoma reveals new recurrently-mutated genes and molecular subgroups. Nat Commun (2013) 1.62
Expanding the computational toolbox for mining cancer genomes. Nat Rev Genet (2014) 1.60
Novel recurrently mutated genes in African American colon cancers. Proc Natl Acad Sci U S A (2015) 1.57
Cancer genome-sequencing study design. Nat Rev Genet (2013) 1.55
Mutational landscape of mucinous ovarian carcinoma and its neoplastic precursors. Genome Med (2015) 1.50
Comprehensive mutational analysis of primary and relapse acute promyelocytic leukemia. Leukemia (2016) 1.45
Recurrent and functional regulatory mutations in breast cancer. Nature (2017) 1.39
The mutational landscape of phosphorylation signaling in cancer. Sci Rep (2013) 1.39
Multiscale mutation clustering algorithm identifies pan-cancer mutational clusters associated with pathway-level changes in gene expression. PLoS Comput Biol (2017) 1.39
Identification of novel mutations by exome sequencing in African American colorectal cancer patients. Cancer (2014) 1.39
FunSeq2: a framework for prioritizing noncoding regulatory variants in cancer. Genome Biol (2014) 1.36
Identifying driver mutations in sequenced cancer genomes: computational approaches to enable precision medicine. Genome Med (2014) 1.31
Integrated analysis of germline and somatic variants in ovarian cancer. Nat Commun (2014) 1.31
Genomic landscape of cutaneous T cell lymphoma. Nat Genet (2015) 1.27
Identification of a pan-cancer oncogenic microRNA superfamily anchored by a central core seed motif. Nat Commun (2013) 1.19
Benchmarking mutation effect prediction algorithms using functionally validated cancer-related missense mutations. Genome Biol (2014) 1.19
Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations. Nat Genet (2016) 1.15
Advances for studying clonal evolution in cancer. Cancer Lett (2013) 1.14
NCG 4.0: the network of cancer genes in the era of massive mutational screenings of cancer genomes. Database (Oxford) (2014) 1.10
The molecular diversity of Luminal A breast tumors. Breast Cancer Res Treat (2013) 1.07
Integrated exome and transcriptome sequencing reveals ZAK isoform usage in gastric cancer. Nat Commun (2014) 1.06
Retracted Mutation pattern is an influential factor on functional mutation rates in cancer. Cancer Cell Int (2016) 1.06
Genomic landscape of liposarcoma. Oncotarget (2015) 1.04
Patterns and functional implications of rare germline variants across 12 cancer types. Nat Commun (2015) 1.02
e-Driver: a novel method to identify protein regions driving cancer. Bioinformatics (2014) 1.00
Aberrant RNA splicing in cancer; expression changes and driver mutations of splicing factor genes. Oncogene (2015) 1.00
DriverDB: an exome sequencing database for cancer driver gene identification. Nucleic Acids Res (2013) 0.99
A Pan-Cancer Catalogue of Cancer Driver Protein Interaction Interfaces. PLoS Comput Biol (2015) 0.98
DawnRank: discovering personalized driver genes in cancer. Genome Med (2014) 0.98
KRAS and CREBBP mutations: a relapse-linked malicious liaison in childhood high hyperdiploid acute lymphoblastic leukemia. Leukemia (2015) 0.96
Genetics and Prognostication in Splenic Marginal Zone Lymphoma: Revelations from Deep Sequencing. Clin Cancer Res (2015) 0.96
Deep sequencing as a probe of normal stem cell fate and preneoplasia in human epidermis. Proc Natl Acad Sci U S A (2015) 0.96
Whole-exome sequencing of muscle-invasive bladder cancer identifies recurrent mutations of UNC5C and prognostic importance of DNA repair gene mutations on survival. Clin Cancer Res (2014) 0.95
Identification of significantly mutated regions across cancer types highlights a rich landscape of functional molecular alterations. Nat Genet (2015) 0.94
SomInaClust: detection of cancer genes based on somatic mutation patterns of inactivation and clustering. BMC Bioinformatics (2015) 0.93
Advances in computational approaches for prioritizing driver mutations and significantly mutated genes in cancer genomes. Brief Bioinform (2015) 0.91
Predicting cancer drivers: are we there yet? Genome Med (2012) 0.89
Bioinformatics pipelines for targeted resequencing and whole-exome sequencing of human and mouse genomes: a virtual appliance approach for instant deployment. PLoS One (2014) 0.89
FOXA1 mutations in hormone-dependent cancers. Front Oncol (2013) 0.89
Pan-Cancer Analysis of Mutation Hotspots in Protein Domains. Cell Syst (2015) 0.89
Clonal architectures and driver mutations in metastatic melanomas. PLoS One (2014) 0.89
The kinome 'at large' in cancer. Nat Rev Cancer (2016) 0.88
OncodriveROLE classifies cancer driver genes in loss of function and activating mode of action. Bioinformatics (2014) 0.88
Mutational landscapes of tongue carcinoma reveal recurrent mutations in genes of therapeutic and prognostic relevance. Genome Med (2015) 0.87
Profiling of somatic mutations in acute myeloid leukemia with FLT3-ITD at diagnosis and relapse. Blood (2015) 0.86
NCG 5.0: updates of a manually curated repository of cancer genes and associated properties from cancer mutational screenings. Nucleic Acids Res (2015) 0.86
The genomic landscape of fibrolamellar hepatocellular carcinoma: whole genome sequencing of ten patients. Oncotarget (2015) 0.86
DOTS-Finder: a comprehensive tool for assessing driver genes in cancer genomes. Genome Med (2014) 0.86
Visualizing genome and systems biology: technologies, tools, implementation techniques and trends, past, present and future. Gigascience (2015) 0.85
Computational methods and resources for the interpretation of genomic variants in cancer. BMC Genomics (2015) 0.85
Precision medicine for metastatic breast cancer-limitations and solutions. Nat Rev Clin Oncol (2015) 0.85
Revealing selection in cancer using the predicted functional impact of cancer mutations. Application to nomination of cancer drivers. BMC Genomics (2013) 0.85
Protein-structure-guided discovery of functional mutations across 19 cancer types. Nat Genet (2016) 0.84
Current strategies for mutation detection in phenotype-driven screens utilising next generation sequencing. Mamm Genome (2015) 0.84
Systematic discovery of complex insertions and deletions in human cancers. Nat Med (2015) 0.83
OncodriveFML: a general framework to identify coding and non-coding regions with cancer driver mutations. Genome Biol (2016) 0.83
Reliably Detecting Clinically Important Variants Requires Both Combined Variant Calls and Optimized Filtering Strategies. PLoS One (2015) 0.83
Evaluating the evaluation of cancer driver genes. Proc Natl Acad Sci U S A (2016) 0.83
Collection, integration and analysis of cancer genomic profiles: from data to insight. Curr Opin Genet Dev (2014) 0.82
Evaluation and integration of cancer gene classifiers: identification and ranking of plausible drivers. Sci Rep (2015) 0.82
Exome-Scale Discovery of Hotspot Mutation Regions in Human Cancer Using 3D Protein Structure. Cancer Res (2016) 0.82
LARVA: an integrative framework for large-scale analysis of recurrent variants in noncoding annotations. Nucleic Acids Res (2015) 0.81
Identification of collaborative driver pathways in breast cancer. BMC Genomics (2014) 0.81
Frequent mutations in acetylation and ubiquitination sites suggest novel driver mechanisms of cancer. Genome Med (2016) 0.81
Whole transcriptome sequencing identifies tumor-specific mutations in human oral squamous cell carcinoma. BMC Med Genomics (2013) 0.81
Simultaneous inference of cancer pathways and tumor progression from cross-sectional mutation data. J Comput Biol (2015) 0.80
MUFFINN: cancer gene discovery via network analysis of somatic mutation data. Genome Biol (2016) 0.80
An Evolutionary Approach for Identifying Driver Mutations in Colorectal Cancer. PLoS Comput Biol (2015) 0.80
TP53 mutations, tetraploidy and homologous recombination repair defects in early stage high-grade serous ovarian cancer. Nucleic Acids Res (2015) 0.80
Heterozygous colon cancer-associated mutations of SAMHD1 have functional significance. Proc Natl Acad Sci U S A (2016) 0.80
Exome sequencing of lymphomas from three dog breeds reveals somatic mutation patterns reflecting genetic background. Genome Res (2015) 0.79
Noncoding somatic and inherited single-nucleotide variants converge to promote ESR1 expression in breast cancer. Nat Genet (2016) 0.79
ContrastRank: a new method for ranking putative cancer driver genes and classification of tumor samples. Bioinformatics (2014) 0.79
Systematic analysis of somatic mutations impacting gene expression in 12 tumour types. Nat Commun (2015) 0.79
Sparse expression bases in cancer reveal tumor drivers. Nucleic Acids Res (2015) 0.79
Genomic tools in acute myeloid leukemia: From the bench to the bedside. Cancer (2014) 0.79
Algorithmic methods to infer the evolutionary trajectories in cancer progression. Proc Natl Acad Sci U S A (2016) 0.79
Statistically identifying tumor suppressors and oncogenes from pan-cancer genome-sequencing data. Bioinformatics (2015) 0.79
Exome sequencing reveals recurrent REV3L mutations in cisplatin-resistant squamous cell carcinoma of head and neck. Sci Rep (2016) 0.78
The Sequence Alignment/Map format and SAMtools. Bioinformatics (2009) 232.39
The Protein Data Bank. Nucleic Acids Res (2000) 187.10
KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res (2000) 117.00
A method and server for predicting damaging missense mutations. Nat Methods (2010) 78.53
Integrated genomic analyses of ovarian carcinoma. Nature (2011) 47.72
ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res (2010) 43.51
Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc (2009) 38.62
The Pfam protein families database. Nucleic Acids Res (2009) 37.98
A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science (1994) 36.53
Somatic mutations affect key pathways in lung adenocarcinoma. Nature (2008) 30.02
Reactome: a knowledgebase of biological pathways. Nucleic Acids Res (2005) 20.05
SMART: a web-based tool for the study of genetically mobile domains. Nucleic Acids Res (2000) 17.77
Linkage of early-onset familial breast cancer to chromosome 17q21. Science (1990) 16.21
The Catalogue of Somatic Mutations in Cancer (COSMIC). Curr Protoc Hum Genet (2008) 16.09
Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science (2003) 13.19
Predicting the functional impact of protein mutations: application to cancer genomics. Nucleic Acids Res (2011) 10.99
Inference of patient-specific pathway activities from multi-dimensional cancer genomics data using PARADIGM. Bioinformatics (2010) 8.44
PROSITE, a protein domain database for functional characterization and annotation. Nucleic Acids Res (2009) 7.47
Comment on "The consensus coding sequences of human breast and colorectal cancers". Science (2007) 5.88
A decade's perspective on DNA sequencing technology. Nature (2011) 5.61
BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases. Cancer (2005) 5.57
Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary. J Pathol (2010) 5.23
A novel signaling pathway impact analysis. Bioinformatics (2008) 5.06
Frequent mutation of the PIK3CA gene in ovarian and breast cancers. Clin Cancer Res (2005) 4.14
A multidimensional analysis of genes mutated in breast and colorectal cancers. Genome Res (2007) 4.09
Oncogenic mutations of the p53 tumor suppressor: the demons of the guardian of the genome. Cancer Res (2000) 3.30
SUPERFAMILY--sophisticated comparative genomics, data mining, visualization and phylogeny. Nucleic Acids Res (2008) 3.07
CanPredict: a computational tool for predicting cancer-associated missense mutations. Nucleic Acids Res (2007) 2.86
Prioritization of driver mutations in pancreatic cancer using cancer-specific high-throughput annotation of somatic mutations (CHASM). Cancer Biol Ther (2010) 2.33
Mitochondrial intermembrane junctional complexes and their role in cell death. J Physiol (2000) 1.86
Forkhead box M1 transcription factor: a novel target for cancer therapy. Cancer Treat Rev (2009) 1.63
PathScan: a tool for discerning mutational significance in groups of putative cancer genes. Bioinformatics (2011) 1.46
The mutations and potential targets of the forkhead transcription factor FOXL2. Mol Cell Endocrinol (2007) 1.03
Ryanodine receptor expression correlates with tumor grade in breast cancer. Pathol Oncol Res (2008) 0.96
Initial sequencing and comparative analysis of the mouse genome. Nature (2002) 96.15
A second generation human haplotype map of over 3.1 million SNPs. Nature (2007) 85.39
Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature (2007) 75.09
An obesity-associated gut microbiome with increased capacity for energy harvest. Nature (2006) 44.35
Evolutionarily conserved elements in vertebrate, insect, worm, and yeast genomes. Genome Res (2005) 44.08
Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell (2010) 39.09
DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome. Nature (2008) 38.13
Recurring mutations found by sequencing an acute myeloid leukemia genome. N Engl J Med (2009) 33.09
Whole-genome sequencing and variant discovery in C. elegans. Nat Methods (2008) 31.92
Mapping and sequencing of structural variation from eight human genomes. Nature (2008) 30.28
Somatic mutations affect key pathways in lung adenocarcinoma. Nature (2008) 30.02
Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet (2010) 23.08
International network of cancer genome projects. Nature (2010) 20.35
Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med (2013) 19.87
Genome remodelling in a basal-like breast cancer metastasis and xenograft. Nature (2010) 19.68
The B73 maize genome: complexity, diversity, and dynamics. Science (2009) 18.73
BreakDancer: an algorithm for high-resolution mapping of genomic structural variation. Nat Methods (2009) 18.41
Evolution of genes and genomes on the Drosophila phylogeny. Nature (2007) 18.01
Genome-wide detection and characterization of positive selection in human populations. Nature (2007) 17.27
Characterizing the cancer genome in lung adenocarcinoma. Nature (2007) 16.48
Evolutionary and biomedical insights from the rhesus macaque genome. Science (2007) 16.21
Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. Cancer Cell (2010) 16.12
VarScan: variant detection in massively parallel sequencing of individual and pooled samples. Bioinformatics (2009) 16.04
VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. Genome Res (2012) 15.90
Extending assembly of short DNA sequences to handle error. Bioinformatics (2007) 14.46
Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing. Nature (2012) 14.33
Integrated genomic characterization of endometrial carcinoma. Nature (2013) 14.29
DNMT3A mutations in acute myeloid leukemia. N Engl J Med (2010) 14.07
The genome sequence of Caenorhabditis briggsae: a platform for comparative genomics. PLoS Biol (2003) 13.32
Mapping copy number variation by population-scale genome sequencing. Nature (2011) 12.55
The male-specific region of the human Y chromosome is a mosaic of discrete sequence classes. Nature (2003) 12.44
The genetic basis of early T-cell precursor acute lymphoblastic leukaemia. Nature (2012) 9.89
De novo gene disruptions in children on the autistic spectrum. Neuron (2012) 9.69
The origin and evolution of mutations in acute myeloid leukemia. Cell (2012) 9.66
Complete Khoisan and Bantu genomes from southern Africa. Nature (2010) 9.06
A high-resolution map of human evolutionary constraint using 29 mammals. Nature (2011) 8.67
Comparison of genome degradation in Paratyphi A and Typhi, human-restricted serovars of Salmonella enterica that cause typhoid. Nat Genet (2004) 8.60
A catalog of reference genomes from the human microbiome. Science (2010) 8.10